| dbo:abstract | - 4-Fluorophenibut (developmental code name CGP-11130; also known as β-(4-fluorophenyl)-γ-aminobutyric acid or β-(4-fluorophenyl)-GABA) is a GABAB receptor agonist which was never marketed. It is selective for the GABAB receptor over the GABAA receptor (IC50 = 1.70 μM and > 100 μM, respectively). The drug is a GABA analogue and is closely related to baclofen (β-(4-chlorophenyl)-GABA), tolibut (β-(4-methylphenyl)-GABA), and phenibut (β-phenyl-GABA). It is less potent as a GABAB receptor agonist than baclofen but more potent than phenibut. The substance is sometimes referred to as 4F-phenibut or F-phenibut and colloquially as fluorobut. (en)
- 4-氨基-3-(4-氟苯基)丁酸或β-氨基甲基-4-氟苯丙酸（研发代号CGP-11130）是一种有机化合物，化学式为C10H12FNO2。它是GABAB受体激动剂，但从未上市。它可由4-硝基-3-(4-氟苯基)丁醛经氧化至羧酸，再由硼氢化钠还原硝基，调节pH至3~4得到。 立陶宛 和匈牙利的法律将其禁售。 (zh)
|
| dbo:casNumber | |
| dbo:fdaUniiCode | |
| dbo:pubchem | |
| dbo:thumbnail | |
| dbo:wikiPageID | |
| dbo:wikiPageLength | - 3539 (xsd:nonNegativeInteger)
|
| dbo:wikiPageRevisionID | |
| dbo:wikiPageWikiLink | |
| dbp:c | |
| dbp:casNumber | |
| dbp:chemspiderid | |
| dbp:f | |
| dbp:h | |
| dbp:iupacName | |
| dbp:n | |
| dbp:o | |
| dbp:pubchem | |
| dbp:routesOfAdministration | |
| dbp:smiles | |
| dbp:stdinchi | |
| dbp:stdinchikey | - QWHXHLDNSXLAPX-UHFFFAOYSA-N (en)
|
| dbp:synonyms | - CGP-11130; β--γ-aminobutyric acid; β--GABA; Baflofen; Fluorophenibut; F-Phenibut; Fluoribut (en)
|
| dbp:unii | |
| dbp:wikiPageUsesTemplate | |
| dcterms:subject | |
| rdf:type | |
| rdfs:comment | - 4-氨基-3-(4-氟苯基)丁酸或β-氨基甲基-4-氟苯丙酸（研发代号CGP-11130）是一种有机化合物，化学式为C10H12FNO2。它是GABAB受体激动剂，但从未上市。它可由4-硝基-3-(4-氟苯基)丁醛经氧化至羧酸，再由硼氢化钠还原硝基，调节pH至3~4得到。 立陶宛 和匈牙利的法律将其禁售。 (zh)
- 4-Fluorophenibut (developmental code name CGP-11130; also known as β-(4-fluorophenyl)-γ-aminobutyric acid or β-(4-fluorophenyl)-GABA) is a GABAB receptor agonist which was never marketed. It is selective for the GABAB receptor over the GABAA receptor (IC50 = 1.70 μM and > 100 μM, respectively). The drug is a GABA analogue and is closely related to baclofen (β-(4-chlorophenyl)-GABA), tolibut (β-(4-methylphenyl)-GABA), and phenibut (β-phenyl-GABA). It is less potent as a GABAB receptor agonist than baclofen but more potent than phenibut. (en)
|
| rdfs:label | - 4-Fluorophenibut (en)
- 4-氨基-3-(4-氟苯基)丁酸 (zh)
|
| owl:sameAs | |
| prov:wasDerivedFrom | |
| foaf:depiction | |
| foaf:isPrimaryTopicOf | |
| isdbo:wikiPageRedirects of | |
| isdbo:wikiPageWikiLink of | |
| isfoaf:primaryTopic of | |
